US 10022375
Methods and compositions for inhibition of polymerase
granted A61KA61K31/196A61K31/215
Quick answer
US patent 10022375 (Methods and compositions for inhibition of polymerase) held by BioCryst Pharmaceuticals, Inc. expires Mon Jul 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BioCryst Pharmaceuticals, Inc.
- Grant date
- Tue Jul 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 32
- CPC classes
- A61K, A61K31/196, A61K31/215, A61K31/351, A61K31/519